Reshma Rangwala, EVP and Chief Medical Officer at Karyopharm Therapeutics Inc. ($KPTI), sold shares on the open market three times in the last year for a total of about $53,000. Her most recent sale occurred on March 2, 2026. These sales rank 10,329th among 11,678 individual insiders, below the average sale amount of 8.6 million and 6.4 transactions per insider. She made no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Karyopharm Therapeutics Inc. | $KPTI | Rangwala Reshma | EVP & Chief Medical Officer | S | Common Stock | 5066 | $9.41 | 56,739.0000 | 18,343,968 | 8.20% | 0.03% |
| Jan. 31, 2026 | Karyopharm Therapeutics Inc. | $KPTI | Rangwala Reshma | EVP & Chief Medical Officer | A | Common Stock | 32415 | $0.00 | 61,805.0000 | 17,050,876,000 | 110.29% | 0.00% |
| Sept. 12, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Rangwala Reshma | EVP & Chief Medical Officer | A | Common Stock | 945 | $0.00 | 29,798.0000 | 126,240,054 | 3.28% | 0.00% |
| Sept. 15, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Rangwala Reshma | EVP & Chief Medical Officer | S | Common Stock | 408 | $6.43 | 29,390.0000 | 126,240,054 | 1.37% | 0.00% |
| April 23, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Rangwala Reshma | EVP & Chief Medical Officer | S | Common Stock | 419 | $6.17 | 28,853.0000 | 126,240,054 | 1.43% | 0.00% |
| March 4, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Rangwala Reshma | EVP & Chief Medical Officer | S | Common Stock | 3587 | $6.29 | 29,272.0000 | 126,240,054 | 10.92% | 0.00% |
| Feb. 28, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Rangwala Reshma | EVP & Chief Medical Officer | A | Stock Option (right to buy) | 10833 | $0.00 | 10,833.0000 | 126,240,054 | 9999.99% | 0.01% |
| Feb. 28, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Rangwala Reshma | EVP & Chief Medical Officer | A | Stock Option (right to buy) | 9166 | $0.00 | 9,166.0000 | 126,240,054 | 9999.99% | 0.01% |
| Feb. 28, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Rangwala Reshma | EVP & Chief Medical Officer | A | Common Stock | 4583 | $0.00 | 32,859.0000 | 126,240,054 | 16.21% | 0.00% |
| Feb. 28, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Rangwala Reshma | EVP & Chief Medical Officer | A | Common Stock | 5416 | $0.00 | 28,276.0000 | 126,240,054 | 23.69% | 0.00% |
| April 22, 2024 | Karyopharm Therapeutics Inc. | $KPTI | Rangwala Reshma | EVP & Chief Medical Officer | S | Common Stock | 6789 | $1.17 | 342,931.0000 | 0 | 1.94% | 0.00% |
| Feb. 29, 2024 | Karyopharm Therapeutics Inc. | $KPTI | Rangwala Reshma | EVP & Chief Medical Officer | S | Common | 15667 | $1.17 | 355,689.0000 | 0 | 4.22% | 0.00% |
| March 1, 2024 | Karyopharm Therapeutics Inc. | $KPTI | Rangwala Reshma | EVP & Chief Medical Officer | S | Common | 5969 | $1.20 | 349,720.0000 | 0 | 1.68% | 0.00% |
| Feb. 28, 2024 | Karyopharm Therapeutics Inc. | $KPTI | Rangwala Reshma | EVP & Chief Medical Officer | A | Common Stock | 198959 | $0.00 | 371,356.0000 | 0 | 115.41% | 0.00% |
| Jan. 24, 2024 | Karyopharm Therapeutics Inc. | $KPTI | Rangwala Reshma | EVP & Chief Medical Officer | A | Common Stock | 14167 | $0.00 | 172,397.0000 | 0 | 8.95% | 0.00% |
| April 20, 2023 | Karyopharm Therapeutics Inc. | $KPTI | Rangwala Reshma | EVP & Chief Medical Officer | S | Common Stock | 6655 | $4.05 | 158,230.0000 | 0 | 4.04% | 0.00% |
| April 20, 2023 | Karyopharm Therapeutics Inc. | $KPTI | Rangwala Reshma | EVP & Chief Medical Officer | S | Common Stock | 115 | $4.03 | 164,885.0000 | 0 | 0.07% | 0.00% |
| Feb. 28, 2023 | Karyopharm Therapeutics Inc. | $KPTI | Rangwala Reshma | EVP & Chief Medical Officer | A | Common Stock | 100000 | $0.00 | 165,000.0000 | 0 | 153.85% | 0.00% |